This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clarke, J. Articles by Davies, G. Search for Related Content PubMed PubMed Citation Articles by Clarke, J. Articles by Davies, G.

Circulation, Vol 83, 774-777, Copyright © 1991 by American Heart Association

ARTICLES

Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man

J Clarke, N Benjamin, S Larkin, D Webb, A Maseri and G Davies
Department of Cardiovascular Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

BACKGROUND. There is increasing evidence that neuropeptide Y (NPY) contributes to the autonomic control of the circulation. NPY coexists with noradrenaline in perivascular nerve terminals, may be released during sympathetic stimulation, and is a potent constrictor of the human coronary circulation and other vascular beds. In vitro studies show that NPY can act either directly on vascular smooth muscle or indirectly by modulation of the presynaptic release or the postsynaptic actions of noradrenaline. It is unclear to what extent these mechanisms operate in vivo. METHODS AND RESULTS. The effect on forearm blood flow of intra-arterial NPY was studied in six volunteers during coinfusion of noradrenaline and during reflex sympathetic stimulation induced by lower-body negative pressure. NPY alone induced a dose-dependent reduction of forearm blood flow in all subjects studied, to a maximum of 49 +/- 6.1%. The reduction of flow during infusion of noradrenaline alone was 42 +/- 8%. The response to noradrenaline was unaffected by coinfusion of a threshold constrictor dose of NPY (50 pmol/min). Furthermore, the reflex sympathetic vasoconstrictor response to 20 cm H2O of lower-body negative pressure was similar in both the infused and control arms during the infusion of 50 pmol/min NPY. The response to noradrenaline was abolished by alpha-blockade with phentolamine, but the flow reduction induced by NPY was unaffected by alpha-blockade. CONCLUSIONS. NPY is a potent constrictor of human forearm resistance vessels and has a direct effect independent of alpha-receptors. NPY has no detectable modulating effect in vivo on the action of endogenous or infused noradrenaline.

This article has been cited by other articles:

				D. P. Stephens, A. R. Saad, L. A. T. Bennett, W. A. Kosiba, and J. M. Johnson Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1404 - H1409. [Abstract] [Full Text] [PDF]

				A. L'Abbate, G. Sambuceti, S. Haunso, and J. Schneider-Eicke Methods for evaluating coronary microvasculature in humans Eur. Heart J., September 2, 1999; 20(18): 1300 - 1313. [PDF]

				L. V. Schuerch, L. M. Linder, E. Grouzmann, and W. E. Haefeli Human neuropeptide Y potentiates alpha 1-adrenergic blood pressure responses in vivo Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H760 - H766. [Abstract] [Full Text] [PDF]

				L. Linder, B. M. Lautenschlager, and W. E. Haefeli Subconstrictor Doses of Neuropeptide Y Potentiate {alpha}1-Adrenergic Venoconstriction In Vivo Hypertension, September 1, 1996; 28(3): 483 - 487. [Abstract] [Full Text]

				G. A. Rongen, J. W.M. Lenders, J. Lambrou, J. J. Willemsen, H. Van Belle, T. Thien, and P. Smits Presynaptic Inhibition of Norepinephrine Release From Sympathetic Nerve Endings by Endogenous Adenosine Hypertension, April 1, 1996; 27(4): 933 - 938. [Abstract] [Full Text]